Jeanine L. Werner
Expertise in
43
conditions

Dr. Jeanine L. Werner

Hematology Oncology
509 Idlewild Avenue, 
Easton, MD 
Accepting New Patients
Offers Telehealth
Expertise in
43
conditions
509 Idlewild Avenue, 
Easton, MD 

Overview

Jeanine Werner is a Hematologist Oncology provider practicing medicine in Easton, Maryland.

Dr. Werner is highly rated in 43 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor.

Dr. Werner is board certified in ABIM - Hematology - Hematology, 1998 and ABIM - Medical Oncology - Medical Oncology, 1998. She is actively involved in clinical research, participating in 3 clinical trials. Dr. Werner is currently accepting new patients.

Specialties

Hematology Oncology

Licenses

Internal Medicine in MD

Board Certifications

ABIM - Hematology - Hematology, 1998
ABIM - Medical Oncology - Medical Oncology, 1998

Hospital Affiliations

UM Shore Regional Health - Dorchester/Easton
UM Baltimore Washington Medical Center
University Of MD Shore Medical Center At Easton
University Of MD Baltimore Washington Medical Center
University Of MD Shore Medical Ctr At Chestertown
Luminis Health Anne Arundel Medical Center, Inc

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Cancer Center at UM Shore Regional Heath
509 Idlewild Avenue, Easton, MD 21601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Entinostat, Exemestane, Goserelin, Goserelin Acetate
Study Phase: Phase 3
Phase II Trial of Palbociclib With Fulvestrant in Individuals With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Who Have Progressed on Treatment With Palbociclib and an Aromatase Inhibitor
Phase II Trial of Palbociclib With Fulvestrant in Individuals With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Who Have Progressed on Treatment With Palbociclib and an Aromatase Inhibitor
Enrollment Status: Active_not_recruiting
Publish Date: June 05, 2026
Intervention Type: Drug
Study Drugs: Palbociclib, Fulvestrant
Study Phase: Phase 2
P3 Efficacy Evaluation of Enobosarm in Combo With Abemaciclib Compared to Estrogen Blocking Agent for 2nd Line Treatment of ER+HER2- MBC in Patients Who Have Shown Previous Disease Progression on an Estrogen Blocking Agent Plus Palbociclib
P3 Efficacy Evaluation of Enobosarm in Combo With Abemaciclib Compared to Estrogen Blocking Agent for 2nd Line Treatment of ER+HER2- MBC in Patients Who Have Shown Previous Disease Progression on an Estrogen Blocking Agent Plus Palbociclib
Enrollment Status: Terminated
Publish Date: February 26, 2024
Intervention Type: Drug
Study Drugs: Enobosarm, Abemaciclib, Non-steroidal AI or steroidal AI or Fulvestrant
Study Phase: Phase 3
View 2 Less Clinical Trials
Similar Doctors
Expertise in
32
conditions
Dr. Maria R. Baer
Hematology Oncology | Oncology
Expertise in
32
conditions
Dr. Maria R. Baer
Hematology Oncology | Oncology
Referral may be required

Stoler Outpatient Cancer Clinic

22 South Greene Street, Floor 1, 
Baltimore, MD 
 (44.9 miles away)
410-328-7609
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Maria Baer is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Baer is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Splenectomy. Dr. Baer is board certified in American Board Of Internal Medicine - Hematology, 1984 and American Board Of Internal Medicine - Internal Medicine, 1983. Dr. Baer is currently accepting new patients.

Expertise in
28
conditions
Dr. Aaron P. Rapoport
Hematology Oncology | Oncology
Expertise in
28
conditions
Dr. Aaron P. Rapoport
Hematology Oncology | Oncology
Referral may be required

Stoler Outpatient Cancer Clinic

22 South Greene Street, Floor 1, 
Baltimore, MD 
 (44.9 miles away)
410-328-7609
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Aaron Rapoport is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Rapoport is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Multiple Myeloma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Rapoport is board certified in American Board Of Internal Medicine - Internal Medicine, 1989 and American Board Of Internal Medicine - Hematology, 1992. Dr. Rapoport is currently accepting new patients.

Expertise in
29
conditions
Dr. Carol K. Tweed
Hematology Oncology
Expertise in
29
conditions
Dr. Carol K. Tweed
Hematology Oncology
Referral may be required

Cancer Center At UM Shore Regional Heath

509 Idlewild Avenue, 
Easton, MD 
 (0.1 miles away)
410-820-6800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Carol Tweed is a Hematologist Oncology provider practicing medicine in Easton, Maryland. Dr. Tweed is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and HER2 Negative Breast Cancer. Dr. Tweed is board certified in ABIM - Medical Oncology - Medical Oncology, 2008 and ABIM - Hematology - Hematology, 2013. Dr. Tweed is currently accepting new patients.

Frequently Asked Questions about Dr. Jeanine L. Werner

How do I make an appointment with Dr. Jeanine L. Werner?

You can book an appointment with Dr. Jeanine L. Werner by calling their office at 410-820-6800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeanine L. Werner a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeanine L. Werner is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeanine L. Werner specialize in?

While Dr. Jeanine L. Werner is a Hematology Oncology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Ovarian Carcinosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Jeanine L. Werner accept my insurance?

Dr. Jeanine L. Werner accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-820-6800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Werner's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 35 Advanced Conditions
    View All 126 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile